The jun and fos protein families are both required for cell cycle progression in fibroblasts.
Molecular and Cellular Biology · 1991-09 · 11 (9) · 4466-4472
DOI: 10.1128/mcb.11.9.4466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Biology, online erschienen am 01.09.1991. Verfasst von K Kovary und 1 weiteren Autor:innen. Die Arbeit wurde bisher 199-mal zitiert (Crossref).
Abstract (Originalsprache)
The expression of different members of the Jun and Fos families of transcription factors is rapidly induced following serum stimulation of quiescent fibroblasts. To determine whether these proteins are required for cell cycle progression, we microinjected affinity-purified antibodies directed against c-Fos, FosB, Fra-1, c-Jun, JunB, and JunD, and antibodies that recognize either the Fos or the Jun family of proteins, into Swiss 3T3 cells and determined their effects in cell cycle progression by monitoring DNA synthesis. We found that microinjection of anti-Fos and anti-Jun family antibodies efficiently blocked the entrance to the S phase of serum-stimulated or asynchronously growing cells. However, the antibodies against single members of the Fos family only partially inhibited DNA synthesis. In contrast, all three Jun antibodies prevented DNA synthesis more effectively than did any of the anti-Fos antibodies.
Zitieren
APA
Kovary, K., & Bravo, R. (1991). The jun and fos protein families are both required for cell cycle progression in fibroblasts. Molecular and Cellular Biology, 11(9), 4466-4472. https://doi.org/10.1128/mcb.11.9.4466
Vancouver
Kovary K, Bravo R. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Molecular and Cellular Biology. 1991;11(9):4466-4472. doi:10.1128/mcb.11.9.4466
BibTeX
@article{Kovary1991,
author = {Kovary, K and Bravo, R},
title = {The jun and fos protein families are both required for cell cycle progression in fibroblasts},
journal = {Molecular and Cellular Biology},
year = {1991},
volume = {11},
number = {9},
pages = {4466--4472},
doi = {10.1128/mcb.11.9.4466}
}
EUVIMED